Arrowhead Research reported $0 in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 0.17M 0.08M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Anika Therapeutics ANIK:US $ 0M 0M
Arena Pharmaceuticals ARNA:US $ 38.78M 1.25M
Arrowhead Research ARWR:US $ 0 0
Bluebird Bio BLUE:US $ 0M 0M
Cerulean Pharma CERU:US $ 0 0
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Heron Therapeutics HRTX:US $ 148.98M 148.98M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
IONIS PHARMACEUT IONS:US $ 1240.7M 369.78M
Ligand Pharmaceuticals LGND:US $ 315.32M 36.99M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 328M 190M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 26491M 908M
Opko Health OPK:US $ 189.73M 40.89M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 31.84M 0.32M